OPENING OF BANKRUPTCY

Quantoom Biosciences

Export PDF
Financial year 2023 · closed on 31/12/2023
Net result
-14,2 M €
-22.9% YoY
Revenue
8,3 M €
Equity
-1,2 M €
-112.1% YoY
Workforce
69,1 ETP
+39.9% YoY

Company — Opening of bankruptcy.

What does Quantoom Biosciences do?

Quantoom Biosciences is a Public limited company incorporated in 2020. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Nivelles. It employs on average 69,1 ETP workers (FTE).

Legal situation
● Opening of bankruptcy
BCE/KBO no. / VAT
BE 0744.643.858
Incorporation
02/03/2020
Legal form
Public limited company
Registered office
rue de la Maitrise 11
1400 Nivelles · WallonieSee on map
Contributed capital
865 614,41 €
Latest accounts
31/12/2023
Average workforce
69,1 ETP
Activities (NACE)
21201Manufacture of pharmaceutical preparations· main21201Manufacture of pharmaceutical preparations72101Research and experimental development on natural sciences and engineering72110Research and experimental development on biotechnology
Joint committees (1)
  • 207
Signals
Good liquidityHealthy social debtsHigh revenue
View the BCE/KBO Public Search record →
Health score
Available with a Rovalta subscriptionTry for 7 days
Recommended credit limit
✦ Verdict · Analyst summary
Financials

Trend over 3 financial years

202320222021
Income statement
Revenue8,3 M €––
EBITDA-9,3 M €-8 M €-5,4 M €
Operating result-14,4 M €-11,5 M €-7,8 M €
Net result-14,2 M €-11,6 M €-7,7 M €
Balance sheet
Equity-1,2 M €9,7 M €8,6 M €
Total assets57,3 M €34,2 M €30,6 M €
Cash11,1 M €7,1 M €5,4 M €
Debts12,1 M €7,9 M €8,4 M €
Other
Workforce69,1 ETP49,4 ETP40,1 ETP
Governance

Board of directors

Seen on filing of 31/12/2023 · 6 active · 3 ended

Active mandates

ANTROBUS

Director · since 17 juin 2021 · until 17 juin 2027 · 0735.357.394

Represented by Sara Kate ANTROBUS

Active
Jean-Paul PRIEELS

Director · since 19 février 2021 · until 31 décembre 2023

Active
Aziz KABEER

Director · since 26 juin 2020 · until 31 décembre 2023

Active
Pierre MORGON

Director · since 26 juin 2020 · until 31 décembre 2023

Active
Hugues BULTOT

Director · since 02 mars 2020 · until 18 juin 2026

Active
José CASTILLO

Managing director · since 02 mars 2020 · until 18 juin 2026

Active

Ended mandates

Jean-Paul PRIEELS

Director · since 19 février 2021 · until 18 juin 2026

Ended
Aziz KABEER

Director · since 26 juin 2020 · until 18 juin 2026

Ended
Pierre MORGON

Director · since 26 juin 2020 · until 18 juin 2026

Ended
At this address

Other companies at this address

CompanyCBE no.
Phoenix Biosciences● Active
1027.640.071
Quantoom Bioservices● Active
0779.337.887
Annual accounts

Full financial information

2023202220212020
Type of accountFull modelFull modelFull modelFull model
Start of the financial year01/01/202301/01/202201/01/202128/02/2020
Closing of the financial year31/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months11 months
Filing date04/07/202412/07/202322/07/202218/06/2021
General meeting28/06/202430/06/202330/06/202217/06/2021
Currency of the financial yearEUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls
Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days
Filings

Annual accounts filings

4 filings with the NBB

ModelClosingGeneral meetingFiledLanguageDocument
Full model31/12/202328/06/202404/07/2024FrenchPDF
Full model31/12/202230/06/202312/07/2023FrenchPDF
Full model31/12/202130/06/202222/07/2022FrenchPDF
Full model31/12/202017/06/202118/06/2021FrenchPDF
Estimate

Indicative valuation

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2023 · 6 active · 3 ended

Active mandates

ANTROBUS

Director · since 17 juin 2021 · until 17 juin 2027 · 0735.357.394

Represented by Sara Kate ANTROBUS

Active
Jean-Paul PRIEELS

Director · since 19 février 2021 · until 31 décembre 2023

Active
Aziz KABEER

Director · since 26 juin 2020 · until 31 décembre 2023

Active
Pierre MORGON

Director · since 26 juin 2020 · until 31 décembre 2023

Active
Hugues BULTOT

Director · since 02 mars 2020 · until 18 juin 2026

Active
José CASTILLO

Managing director · since 02 mars 2020 · until 18 juin 2026

Active

Ended mandates

Jean-Paul PRIEELS

Director · since 19 février 2021 · until 18 juin 2026

Ended
Aziz KABEER

Director · since 26 juin 2020 · until 18 juin 2026

Ended
Pierre MORGON

Director · since 26 juin 2020 · until 18 juin 2026

Ended
Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days
Belgian Official Gazette

Belgian Official Gazette publications

  • Capital / shares28/01/2025
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Restructuring21/11/2024
    RUBRIQUE RESTRUCTURATION (FUSION, SCISSION, TRANSFERT PATRIMOINE, ETC...)
    PDF
  • Mandates26/02/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS - DEMISSIONS, NOMINATIONS
    PDF
  • Mandates20/09/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares12/09/2023
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Capital / shares24/11/2022
    CAPITAL, ACTIONS
    PDF
  • Capital / shares20/12/2021
    CAPITAL, ACTIONS - STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …)
    PDF
  • Mandates24/08/2021
    DEMISSIONS, NOMINATIONS
    PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 30/12/2024
    augmentation_capitalUNIVERCELLS
  2. 30/12/2024
    reduction_capital
  3. 01/01/2024
    nominationAlerion BV — administrateur
  4. 01/01/2024
    nominationViva Finance SRL — administrateur
  5. 2023
    Annual accounts 2023-14,2 M €↓
  6. 22/12/2023
    augmentation_capitalUNIVERCELLS
  7. 25/08/2023
    augmentation_capital
  8. 25/08/2023
    reduction_capital
  9. 30/06/2023
    reconductionDeloitte Réviseur d'Entreprises — commissaire
  10. 2022
    Annual accounts 2022-11,6 M €↓
  11. 10/11/2022
    augmentation_capital
  12. 10/11/2022
    reduction_capital
  13. 2021
    Annual accounts 2021-7,7 M €
  14. 02/03/2020
    IncorporationPublic limited company